Cordocentesis‐associated fetal loss and risk factors: single‐center experience with 6650 cases

Abstract

Objectives To identify procedural risk factors associated with fetal loss following cordocentesis and to determine the rate of cordocentesis‐related fetal loss associated with the current cordocentesis protocol used in our institution. Methods This was a retrospective cohort study of pregnancies that underwent midpregnancy cordocentesis in a single center (a tertiary hospital, teaching school), between 1992 and 2018, based on data retrieved from our prospective database. All consecutive cases were validated to retrieve those meeting the eligibility criteria, which included: singleton pregnancy without underlying maternal disease, normal fetus (no structural or chromosomal abnormality or severe disorder), gestational age between 16 and 24 weeks at the time of the procedure and availability of pregnancy outcome. Cases that resulted in termination of pregnancy were excluded. We assessed the effect of prior cordocentesis model training on the fetal‐loss rate and procedure‐related complications, and evaluated potential risk factors of fetal loss secondary to cordocentesis, including procedure difficulty, placenta penetration, prolonged bleeding, fetal bradycardia, puncture site and early gestational age at procedure. Pregnancy outcomes were compared between the study group and a control group of women, who did not undergo cordocentesis, selected randomly at a 1:1 ratio from our obstetric database. Results A total of 10 343 procedures were performed during the study period, of which 6650 met the eligibility criteria and were included in the analysis. The fetal‐loss rate in the first 60 procedures (early practice) of six operators (n = 360 procedures), who did not have prior model training, was significantly higher than that during the early practice of 18 operators (n = 1080 procedures) with prior model training (6.9% vs 1.6%; P < 0.001); whereas the fetal‐loss rate in the next 60 procedures of practice was comparable between the two groups. After excluding the first 360 procedures of the groups without prior model training, the overall fetal‐loss rate in pregnancies that underwent cordocentesis was significantly higher than that in the control group (1.6% vs 1.0%; P < 0.001). Considering the fetal‐loss rate in the normal controls as background loss, the incremental cordocentesis‐associated fetal‐loss rate was 0.6%. Penetration of the placenta (odds ratio (OR), 2.65 (95% CI, 1.71–4.10)), prolonged bleeding from the puncture site (OR, 10.85 (95% CI, 5.27–22.36)) and presence of fetal bradycardia (OR, 3.32 (95% CI, 1.83–6.04)) during cordocentesis were independent risk factors associated with fetal loss. Conclusions Cordocentesis model training markedly reduces fetal loss during the early learning curve of practice. Thus, cordocentesis practice without prior model training should not be acceptable. Significant procedural risk factors for fetal loss secondary to cordocentesis are placental penetration, prolonged bleeding and fetal bradycardia. Cordocentesis‐related fetal loss may be only 0.6%, much lower than the...

Fetal blood sampling in mid‐pregnancy: does it still have a role in prenatal diagnosis?

“…Despite our concerns about the findings of their study 1 , we agree with Tanvisut et al . that, in current standard practice, cordocentesis is a relatively safe procedure associated with a fetal‐loss rate of less than 1%.…”

“…Fetal blood sampling in mid-pregnancy: does it still have a role in prenatal diagnosis? Tanvisut et al recently reported their single-center experience with invasive prenatal diagnosis using cordocentesis in mid-pregnancy 1 . In 6650 procedures performed at 16-24 weeks' gestation during a 27-year period, they reported a cordocentesis-related fetal loss rate of 0.6%, much lower than that observed in previous studies 2,3 .…”

Copy number variations in ultrasonically abnormal late pregnancy fetuses with normal karyotypes

“…Abnormal ultrasound findings in the second and third trimesters of pregnancy allow the detection of a unique group of late developmental manifestations, including major and minor fetal abnormalities or ultrasound soft markers, which do not exist in the first trimester of pregnancy 5 . Because of the lack of technical expertise in hospitals, obstetric ultrasound examination is only carried out in the second and third trimesters of pregnancy and some structural abnormalities are found only later with fetal development, thus resulting in a missed examination time for chorionic villus sampling and amniocentesis (Typically, chorionic villus sampling is performed at 10–12 weeks’ gestation, and amniocentesis is performed at 15–18 weeks’ gestation).…”

Trisomy 8 mosaicism in the placenta: A Danish cohort study of 37 cases and a literature review

“…37,38 However, cordocentesis has become almost a lost skill in Denmark due to the relatively high risk of procedure-induced fetal loss, [39][40][41] although a recent paper reports a risk of fetal loss <1% in practiced hands. 42 Potentially, cordocentesis is a procedure to be considered in cases of T8M in the CVS, if there are no malformations detected, but where the couple wish for a very low residual risk.…”